Novartis and Johnson & Johnson to deprive Europeans of their right to Health

Novartis-Logo (1)

It was the last day of January that the European Commission decided to send a formal complaint against two pharmaceutical giants, Johnson and Johnson and Novartis, over an illegal secret deal that made European cancer patients suffer while it brought huge profits to the American and Swiss multinational accordingly.

After the meticulous research of DG Competition, that as usually, took around 10 years to bear fruit, it has been uncovered that the two of the three biggest Pharmaceutical companies of the world according to Forbes, were having a small party in Netherlands between 2005 and 2006 at the expense of the Dutch cancer patient. According to DG Comp, what was happening back then is that the Dutch branch of Johnson & Johnson in the Netherlands, Janssen-Cilag, had in its payroll for one year and a half a competitive pharmaceutical company specialized in generics called Sandoz. The latter is a proper known unit of the Swiss company Novartis. So, basically, Johnson and Johnson were paying to Novartis a huge amount of money for 17 months. Isn’t that weird? Competitor companies are supposed to have endless board meetings on how to steal money from each other and not sharing bribes. Was 2005 the year that the management of the two powerful companies lost their minds due to burnout?

The Pay for Delay Deal

Well, think again! These people knew very well what they were doing. We are talking here about the anticompetitive bad practice of Pharmaceuticals called “Pay for Delay” where one brand name is bribing the generic drug competitor in order to delay the release of the cheaper generic drug in the market. In our case the generic drug that was deliberately and illegally delayed to launch in the Dutch market is Fentanyl and it is a drug that is mainly used by cancer patients to relieve pain. In a nutshell, these two companies deprived the Dutch cancer patients from the right to be able to buy a much cheaper drug, so that they can save millions of Euros by preventing a market share loss that a cheaper substitute product in the market would bring.

On the antitrust statement of DG Competition on the 31st of January, Mr. Almunia, the EU Competition Commissioner, said: “If our preliminary conclusions are confirmed, the Dutch subsidiaries of Johnson & Johnson and Novartis entered into a so-called “co-promotion” agreement to avoid competing against each other, depriving users of fentanyl in the Netherlands from access to a cheaper pain killer,”… “The commission is determined to fight undue delays in the market entry of generic medicines so that European citizens have access to affordable health care”. The Basque EU Commissioner says it here very well, but he certainly cannot say anything to the Dutch patients that were not given the alternative of cheap Fentanyl for 17 monhts! Can he?

DG Comp is doing Fundraising

Unfortunately, it seems that this antitrust statement can serve only in two things: a) make impression and b) make the Commission richer. If the Commission wins this battle with the pharmaceutical dinosaurs, which we all hope it will, the only benefit will be a few billion Euros for DG Comp. And of course we live in crisis and Mr. Almunia needs to play the role of the Fundraiser but in the end of the day this will not solve the Pay for Delay syndrome that is expanding like a plague in Europe and is menacing significantly public health. I mean, what is 7 billion euros for Johnson and Johnson to pay as fine compared to the millions or billions that the company has probably saved by exercising this anticompetitive covert technique? And of course, we are talking here about one case that goes back 10 years ago and was uncovered now. Who knows how many other similar incidents we had or we have at this moment in Europe happening at the expense of the European citizen, which will never see the light of publicity? Hence, the culminant question here is: What next? How can the European citizen be sure that this kind of corporate bribing will not be repeated in the future?

The European Parliament had an idea

Only a week after the antitrust statement, a new draft law was voted on the 6th of February in the European Parliament that seems relevant to the topic of this story. The basic concept behind that is that European patients should be able to buy cheaper generic medicines. This is an excellent concept. The European Sting and all Europeans welcome this spirit from the European law makers without a doubt. However, the European Parliament only voted in favour of some new deadlines and transparency standards on pricing and reimbursement of generic medicines. As usually, all this will be addressed to the 27 member states.

Of course, this is something that Europe needed to have anyway, because the rules that are now in action and describe these procedures are almost 25 years old (1989). It is true that the procedures were poorly defined and slow while, as Mrs. Antoniya Parvanova, rapporteur from the Alliance of Liberals and Democrats for Europe (ALDE), said, sometimes it took a country up to 700 days to make decisions on pricing and reimbursement of medicines. However, why was this matter brought up in the European Parliament now and not before? Is it to take the next step after Mr. Almunia’s antitrust statement?

I am afraid not. The reasons are twofold:

a)      This vote apparently is not going to stop Pharmaceuticals to pay for delay

b)      The draft law was voted on the 6th of February, when on the 4th was the World Cancer Day. The period that the draft law was voted was a period with numerous events aiming at cancer awareness all around the world. Is it a coincidence that the flash addicted European Parliament voted for this in the beginning of February and not in March?

Overall the draft law is a good reform addressed to member states to improve the European health system as a whole but let’s be honest here. Big Pharmaceuticals will be still free out there to sign golden deals under the table with generic competitors, in order to delay the launch of their product so that they keep the prices and profits high for themselves. Who will touch these people? Or better who can touch these people? Is a few billion fine enough to make them stop?

I guess not. The only cure from this cancer is that the patient, the European citizen, is aware of what exactly is happening behind her back and I hope that with this story the Sting has contributed to that.

the sting Milestone

Featured Stings

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

Climate change brings a host of other risks for businesses

Britain heading to national schism on exit from EU

How has technology changed – and changed us – in the past 20 years?

The anti-vaccine movement shows the peril of a post-truth world

MEPs take stock of the EU’s foreign, security and defence policy priorities

A Sting Exclusive: “Leading by example! EU must push for UN deal to avoid dangerous climate change”, European Parliament Vice-President Ulrike Lunacek cries out from Brussels

How smartphones can close the global skills gap for billions

OECD Donor countries need to reform development finance to meet 2030 pledge

How can we regulate disruptive technologies?

An ageing workforce isn’t a burden. It’s an opportunity

EU climate law: MEPs want to increase emission reductions target to 60% by 2030

Draghi strives to control the unruly exploitation of financial markets by banking leviathans

Ten UN peacekeepers killed in a terrorist attack in northern Mali

Coronavirus: rescEU medical stockpile expands in four Member States

Technology is delivering better access to financial services. Here’s how

Coronavirus: truth and myth on personal risk perception

‘Never give up’: UN chief urges all who serve, marking UN Day

EU steps up aid for Lebanon – European Commissioner for Crisis Management in Beirut

Energy Union: EU’s effort towards a cleaner climate with integrated energy market

Health is nothing but the main consequence of climate change

Could electric vehicles pose a threat to our power systems?

8 fascinating and fearsome frontiers of science you should know about

The banks first to benefit from the new euro trillion ECB plans to print

EU rewards organisations that make eco-innovation pay

“If the job market doesn’t exist, then even the most brilliant Youth Guarantee cannot ensure a job to these young people”, European Youth Forum Secretary General Giuseppe Porcaro on another Sting Exclusive

Comprehensive listening: a tool to humanize Primary Healthcare and medical specialties

How teaching ‘future resilient’ skills can help workers adapt to automation

Traditional finance is failing millennials. Here’s how investing needs to change

Environmental Implementation Review: Commission helps Member States to better apply EU environment rules to protect citizens and enhance their quality of life

Don’t believe the hype: offices are here to stay

Most fish consumers support a ban on fishing endangered species, poll finds

State aid: Commission approves €6 billion Italian schemes to support SMEs affected by coronavirus outbreak

Even in the world’s richest countries, kids might not have what they need to learn at home

Draghi tells the EU Parliament his relaxed policies are here to stay

10th ASEM in Milan and the importance of being one: EU’s big challenge on the way to China

The UK’s River Thames has come back to life – with a seal population to prove it

How leaders can use ‘agile governance’ to drive tech and win trust

On Brexit: the outcome of UK elections next May to be based on false promises?

Brazilian officer a ‘stellar example’ of why more women are needed in UN peacekeeping

‘Grave consequences’ await if new deadly escalation of violence in Gaza continues – top UN official

It is impossible to end HIV without SRHR

Activist investors are more powerful than ever. Here’s what that means for the economy

ECB’s Draghi favours a cheaper euro to serve all Eurozone countries

MEPs and EU ministers agree on closing information gaps to enhance security

The Ecofin Council creates officially the clan of ‘undead’ banks

Strengthen inclusion, participation of people with autism to ‘achieve their full potential’ says UN chief

To save biodiversity, MEPs call for binding targets at global and EU level

3 things you need to know about securing a blockchain

JADE Spring Conference 2018 is on its way: Young entrepreneurs gather in Brussels to shape Europe

Will the end of QE come along with ECB’s inflation target?

Security Council urges ‘maximum restraint’ around Gulf region as Iran and United States trade diplomatic blows in New York

“At the Environment Assembly citizens expect clean, not hot air”, the Head of UN Environment in Europe underscores in a Sting Exclusive

Blockchain is facing a backlash. Can it survive?

Microsoft’s YouthSpark: a kiss of Life to European Youth from the European Parliament

5 ways to net a sustainable future for aquaculture

Financial services: Commission sets out its equivalence policy with non-EU countries

UN ‘determined to lead by example’ on disability rights: Guterres

Parliament backs measures to cut e-commerce VAT fraud

CO2 can be a valuable raw material, not just a climate killer. Here’s how

How the EU crisis hit countries saved the German and French mega-banks from bankruptcy and still pay the costs

More Stings?

Advertising

Comments

  1. I believe this is one of the so much important information for me.
    And i’m satisfied studying your article. But wanna
    remark on few basic things, The site style is perfect, the articles is in point of fact excellent : D.
    Just right task, cheers

Speak your Mind Here

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s